dronabinol has been researched along with Weight Reduction in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chacko, B; Rajkumar, T | 1 |
| Le Foll, B; Le Strat, Y; Sharkey, KA; Trigo, JM | 1 |
| Amedee, AM; Birke, LL; Lacour, N; LeCapitaine, NJ; Molina, PE; Nichols, WA; Stouwe, CV; Winsauer, PJ | 1 |
| Dalton, VS; Wang, H; Zavitsanou, K | 1 |
| Brett, RR; Lewis, DY | 1 |
| Crouch, GJ; Evetts, MJ; McGregor, IS; Oldfield, BJ; Stefanidis, A; Verty, AN | 1 |
| Abdullah, RA; Akbarali, HI; Cravatt, BF; Kinsey, SG; Lichtman, AH; Long, JZ; Nomura, DK; Owens, RA; Ramesh, D; Ross, GR; Schlosburg, JE; Sim-Selley, LJ | 1 |
| Comer, SD; Cooper, ZD; Foltin, RW; Haney, M; Hart, CL; Vosburg, SK | 1 |
| Businco, F; Dessi, C; Fadda, P; Fattore, L; Fratta, W; Goldberg, SR; Pigliacampo, B; Satta, V; Scherma, M | 1 |
| Morley, JE | 1 |
| Avraham, Y; Ben-Shushan, D; Berry, EM; Breuer, A; Fink, N; Katz, V; Okon, A; Zolotarev, O | 1 |
| Anggadiredja, K; Shoyama, Y; Tanaka, H; Watanabe, S; Yamaguchi, T; Yamamoto, T | 1 |
| Bowers, D; Cohen, CJ; DeJesus, E; Pearce, D; Rodwick, BM | 1 |
| Beal, JE; Bellman, P; Laubenstein, L; Lefkowitz, L; Morales, JO; Olson, R; Plasse, TF; Shepard, KV; Yangco, B | 1 |
| Cat, LK; Coleman, RL | 1 |
| Nightingale, SL | 1 |
| Volicer, L | 1 |
| Budney, AJ; Hughes, JR; Moore, BA; Novy, PL | 1 |
| Jatoi, A; Loprinzi, CL; Novotny, PJ; Sloan, JA; Windschitl, HE; Yamashita, J | 1 |
3 review(s) available for dronabinol and Weight Reduction
| Article | Year |
|---|---|
Orexigenic and anabolic agents.
Topics: Aged; Analgesics, Non-Narcotic; Animals; Appetite; Appetite Stimulants; Dronabinol; Gastric Emptying; Humans; Megestrol Acetate; Weight Loss | 2002 |
Treatment for HIV wasting syndrome.
Topics: Anorexia; Clinical Trials as Topic; Dronabinol; Enteral Nutrition; HIV Infections; Humans; Megestrol; Parenteral Nutrition; Retrospective Studies; Syndrome; Weight Loss | 1994 |
Tube feeding in Alzheimer's disease is avoidable.
Topics: Alzheimer Disease; Antidepressive Agents; Contraindications; Depression; Dronabinol; Eating; Enteral Nutrition; Humans; Psychotropic Drugs; Sertraline; Weight Loss | 1998 |
4 trial(s) available for dronabinol and Weight Reduction
| Article | Year |
|---|---|
A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers.
Topics: Adult; Affect; Analysis of Variance; Anorexia; Antipsychotic Agents; Dibenzothiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Abuse; Middle Aged; Neuropsychological Tests; Placebos; Psychomotor Performance; Quetiapine Fumarate; Secondary Prevention; Self Administration; Sleep Wake Disorders; Substance Withdrawal Syndrome; Weight Loss; Young Adult | 2013 |
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anorexia; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Weight Loss | 1995 |
Marijuana abstinence effects in marijuana smokers maintained in their home environment.
Topics: Adolescent; Adult; Affective Symptoms; Aggression; Ambulatory Care; Behavior, Addictive; Creatinine; Dronabinol; Feeding and Eating Disorders; Female; Humans; Male; Marijuana Abuse; Middle Aged; Personality Inventory; Psychomotor Agitation; Severity of Illness Index; Sleep Wake Disorders; Substance Abuse Detection; Substance Withdrawal Syndrome; Weight Loss | 2001 |
Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents, Hormonal; Down-Regulation; Dronabinol; Drug Therapy, Combination; Female; Humans; Interleukin-6; Male; Megestrol Acetate; Middle Aged; Neoplasms; Quality of Life; Treatment Outcome; Weight Loss | 2002 |
14 other study(ies) available for dronabinol and Weight Reduction
| Article | Year |
|---|---|
The Case | Weeding out the cause of acute kidney injury.
Topics: Acute Kidney Injury; Adult; Creatinine; Dehydration; Dronabinol; Fluid Therapy; Humans; Leukocyte Count; Male; Marijuana Abuse; Oliguria; Vomiting; Weight Loss | 2017 |
Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss?
Topics: Cannabis; Dronabinol; Evidence-Based Medicine; Humans; Marijuana Smoking; Obesity; Plant Extracts; Treatment Outcome; Weight Loss | 2013 |
Chronic Δ⁹-tetrahydrocannabinol administration may not attenuate simian immunodeficiency virus disease progression in female rhesus macaques.
Topics: Animals; CD4-CD8 Ratio; Disease Progression; Dronabinol; Female; Macaca mulatta; Menstrual Cycle; Receptors, CXCR4; Simian Acquired Immunodeficiency Syndrome; Viral Load; Weight Loss | 2014 |
HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat.
Topics: Animals; Autoradiography; Basal Ganglia; Brain; Cerebral Cortex; Cyclohexanols; Down-Regulation; Dronabinol; Male; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Weight Loss | 2009 |
Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2.
Topics: Animals; Anorexia Nervosa; Arachidonic Acids; Benzyl Compounds; Disease Models, Animal; Dronabinol; Energy Intake; Energy Metabolism; Feeding Behavior; Male; Mice; Mice, Inbred C57BL; Motor Activity; Physical Conditioning, Animal; Psychotropic Drugs; Weight Loss | 2010 |
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.
Topics: Adipose Tissue, Brown; Analysis of Variance; Animals; Anorexia; Body Weight; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Eating; Female; Lipid Metabolism; Motor Activity; Rats; Rats, Sprague-Dawley; Thermogenesis; Time Factors; Weight Loss | 2011 |
Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
Topics: Amidohydrolases; Animals; Arachidonic Acid; Behavior, Animal; Benzodioxoles; Brain Chemistry; Cannabinoid Receptor Modulators; Diarrhea; Dronabinol; Electric Stimulation; Endocannabinoids; Hydrolysis; Ileum; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Monoacylglycerol Lipases; Morphine Dependence; Muscle Contraction; Naloxone; Narcotic Antagonists; Piperidines; Prostaglandins; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substance Withdrawal Syndrome; Weight Loss | 2011 |
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.
Topics: Animals; Behavior, Animal; Binge-Eating Disorder; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Inverse Agonism; Drug Tolerance; Endocannabinoids; Energy Intake; Feeding Behavior; Female; Margarine; Piperidines; Pyrazoles; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction; Weight Loss | 2013 |
Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss.
Topics: Animals; Dronabinol; Eating; Female; Maze Learning; Mice; Neurotransmitter Agents; Piperidines; Pyrazoles; Rimonabant; Weight Loss | 2004 |
Decrease in prostaglandin level is a prerequisite for the expression of cannabinoid withdrawal: a quasi abstinence approach.
Topics: Animals; Behavior, Animal; Cannabinoids; Cyclooxygenase Inhibitors; Diclofenac; Dronabinol; Male; Mice; Piperidines; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Rimonabant; Substance Withdrawal Syndrome; Weight Loss | 2005 |
Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.
Topics: Acquired Immunodeficiency Syndrome; Appetite; Body Weight; Dronabinol; Humans; Retrospective Studies; Weight Loss | 2007 |
Drug approval for weight loss in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anorexia; Dronabinol; Humans; Weight Loss | 1993 |
From the Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anorexia; Dronabinol; Humans; Methadone; Mollusca; Opioid-Related Disorders; Shellfish; United States; United States Food and Drug Administration; Vibrio Infections; Weight Loss | 1993 |
Dronabinol found to stimulate appetite and prevent weight loss in patients with HIV infection.
Topics: Appetite; Dronabinol; Feeding and Eating Disorders; HIV Infections; Humans; Weight Loss | 1991 |